2C3D

Revolutionizing Skin Tumor Resection

Health Tech & Life Sciences
Active
Pre-Funding Israel Founded 2023
Last updated 2026-06-18
Total raised
$40K
Last: Grant 2023-10
Stage
Pre-Funding
Founded
2023
Headcount
5
HQ
Israel
Sector
Health Tech & Life Sciences

About

The company is at the forefront of advancing melanoma cancer treatment by integrating state-of-the-art diagnostic methods and digital pathology. Its unique approach is aimed at achieving complete eradication of melanoma through a singular surgical procedure. By studying the functional properties of melanoma, the company aims to enhance treatment outcomes and potentially expand these methods to other types of skin tumors. Committed to advancing medical knowledge, the company is dedicated to reshaping the landscape of skin cancer treatment and making a lasting impact on patients' lives.

Funding history · 1 round · $40K total

2023-10

Q&A

What is 2C3D's primary focus?
2C3D is focused on advancing melanoma cancer treatment by integrating diagnostic methods and digital pathology to achieve complete eradication of melanoma through a single surgical procedure.
When was 2C3D founded?
2C3D was founded in June 2023.
What is 2C3D's total funding to date?
2C3D has raised a total of $40,000 USD.
When was 2C3D's most recent funding round and who participated?
2C3D's most recent funding was a Grant round in October 2023, with participation from Israel Innovation Authority.
Who are the co-founders of 2C3D?
The co-founders of 2C3D are Or Litman, who serves as Co-founder & CEO, and Lior Saban, who is Co-founder & VP R&D.
In which sector does 2C3D primarily operate?
2C3D primarily operates in the Health Tech & Life Sciences sector.
What is the current product stage of 2C3D?
2C3D's product is currently in the R&D stage.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & VP R&D

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business model
B2B2CB2B

Tags

cancercancer-research
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Former namesSkin Sight
Founded2023-6
Employees (exact)5

Radar intelligence

Patents

EPO3